Just diagnosed? Learn more.

A kidney cancer diagnosis can be scary and confusing. You're not alone. KidneyCAN has put together resources to help you navigate a new diagnosis, your treatment options, and living well with cancer.

We Did It!

Thanks to the hard work of many advocates in the kidney cancer community, Congress has allocated $50 million in federal funding for research in 2021. Learn how our team worked for this!

Kidney Cancer Research Summit 2021

Registration is open for the 2021 Kidney Cancer Research Summit. We are also accepting abstracts for original research in translational and basic science, clinical research, and trials in progress.

Making Progress Toward Cures

Our Goals

  • We provide education, resources, and support to kidney cancer patients and caregivers
  • We identify patients’ and researchers’ unmet needs
  • We engage and educate policymakers on the urgency of kidney cancer research funding
  • We urge Congress to fund kidney cancer research
  • We increase CDMRP Kidney Cancer Research Program and NIH funding through advocacy
  • We provide direct funding to promising ideas
  • We propel collaboration and progress in kidney cancer research (Kidney Cancer Research Summit)
  • We grow the community of kidney cancer researchers
  • We support the development of new treatments by educating patients on trial access and enrollment
  • We identify new unmet needs, set new goals, and keep working

Our Mission

Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.

NEWLY DIAGNOSED?

You’re not alone. We’ve put together a Patient Resource Center to help you navigate a new diagnosis and beyond. Learn about kidney cancer, various treatment options, patient education events, and how to live well with cancer.  

BUILD A CARE TEAM

One of the best decisions you can make when facing kidney cancer is to choose an experienced medical team. We’ve put together resources including a checklist of questions for your doctor and a list of NCI comprehensive cancer centers.

For Patients

Advocacy

Research

Join Our Grassroots Army

You might not realize how important it is for the kidney cancer community to advocate in order to make progress toward cures.

What are we advocating for?

Awareness? Funding? Research? Cures?

The answer is — we are advocating for all of those things. We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

The @OncoAlert 🚨@ecancer Weekly RoundUp
July 25-31
Best
@weoncologists 🤠

@jamecancerdoc @DrSGraff @tmprowell @hoperugo @ErikaHamilton9 @DrHBurstein @antgiorda @prat_aleix ...@NicoleKuderer @MichaelGnant @neerajaiims @AlbertBourla @DrChoueiri @MarkYarchoan @CathyEngMD @barlesi

Would you look at these rockstars 🤩

New Uromigos podcast ‘on location’ in Spain. https://anchor.fm/the-uromigos/episodes/Episode-120-The-Uromigos-Paper-of-the-Month-from-Mallorca-e1562qo

Recently diagnosed with COVID-19? Bristol Myers Squibb's COVID treatment trial -- mAb Duo -- is now up and live on the NIH Rise Above COVID site for patients. This Phase 2 trial is for ...COVID-positive patients experiencing symptoms who are standard risk to progressing (not only high risk patients). The Phase 2 trial enrollment is now live in the US at 53 sites.

You may already know that we at KidneyCAN are big proponents for clinical trials. Here's why:

Why should I join a clinical trial?
Clinical trials are part of clinical research and at the heart of all medical advances. Clinical trials look at new ways to prevent, detect, or treat disease.

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments.

The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses.

People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.

Clinical trials offer hope for many people and an opportunity to help researchers find better treatments for others in the future.

Recently diagnosed with COVID-19? Bristol Myers Squibb's COVID treatment trial -- mAb Duo -- is now up and live on the NIH Rise Above COVID site for patients. This Phase 2 trial is for ...COVID-positive patients experiencing symptoms who are standard risk to progressing (not only high risk patients). The Phase 2 trial enrollment is now live in the US at 53 sites.

You may already know that we at KidneyCAN are big proponents for clinical trials. Here's why:

Why should I join a clinical trial?
Clinical trials are part of clinical research and at the heart of all medical advances. Clinical trials look at new ways to prevent, detect, or treat disease.

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments.

The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses.

People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.

Clinical trials offer hope for many people and an opportunity to help researchers find better treatments for others in the future.

A can't-miss event for sure! Rockstar lineup of experts discussing the latest in #kidneycancer research, treatments, and patient education.

We're looking forward to this! ...https://twitter.com/DrChoueiri/status/1420733946514395139

💡Many cancers develop despite excellent "life long health decisions". I spent all day telling my patients that #cancer is NOT their fault.

Can we reduce cancer risk? Yes.
...Can we PREVENT cancer? No.

Exciting news! @BMS #COVID mAb Duo is now live on the @NIH Rise Above COVID site for patients!

https://www.riseabovecovid.org/us/en/
 
This Phase 2 trial is for COVID-positive ...patients experiencing symptoms who are standard risk to progressing (not only high risk). Enroll now in US @ 53 sites

Please get vaccinated. “We can do this!” Thank you @McDonalds for extending this message on your coffee cups. Delta is different. Please make the choice to protect yourself and your loved ones. ...@CDCgov @COVID19nCCC

When we formed KidneyCAN in 2016, the amount of money Congress allocated specifically for kidney cancer research was $0. Through advocacy, we’ve generated $135 million in research funding in five years.

Latest News

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

On June 17th, people from all around the world came together to participate in activities for #WorldKidneyCancerDay, and we’re proud to share what KidneyCAN did in partnership with the IKCC and many other partners from the kidney cancer community. Our goal each year...

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher...

Speak Up for Kidney Cancer Research Funding: District Days 2021

In 2016, Congress allocated $0 in funding dedicated to kidney cancer research. Through the power of advocacy, we have raised that number to $135 million in five years. We need YOU to keep this funding in place. Please plan to join our grassroots army for our second...

Lucinda Peng: Inspired to Speak Up

KidneyCAN is excited to begin a new Spotlight Series, where we’ll introduce you to members of the kidney cancer community whose stories inspire and motivate us in our work. Today, we’d like you to meet Lucinda Peng, from Atlanta, Georgia. Lucinda is a founding member...

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community. 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORY BOARD →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Dr. John T. Wilson: “A Lot of Reason to Hope”

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher today, Dr. John T. Wilson,...

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DISTRICT DAYS →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Dr. John T. Wilson: “A Lot of Reason to Hope”

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher today, Dr. John T. Wilson,...

FACING KIDNEY CANCER →

DIAGNOSIS →

BUILDING A CARE TEAM →

LEARN ABOUT CLINICAL TRIALS →

LIVING WELL WITH KIDNEY CANCER →

DONATE →

CONTACT →

Latest News

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

On June 17th, people from all around the world came together to participate in activities for #WorldKidneyCancerDay, and we’re proud to share what KidneyCAN did in partnership with the IKCC and many other partners from the kidney cancer community. Our goal each year on World Kidney Cancer Day is...

KCRS →

RESEARCH OPPORTUNITIES →

ADVOCATE WITH KIDNEYCAN →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Dr. John T. Wilson: “A Lot of Reason to Hope”

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher today, Dr. John T. Wilson,...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

On June 17th, people from all around the world came together to participate in activities for #WorldKidneyCancerDay, and we’re proud to share what KidneyCAN did in partnership with the IKCC and many other partners from the kidney cancer community. Our goal each year on World Kidney Cancer Day is...